Arginase, Type II Produits
(Arginase, Type II (ARG2))
Catégories
Arginase catalyzes the hydrolysis of arginine to ornithine and urea. At least two isoforms of mammalian arginase exists (types I and II) which differ in their tissue distribution, subcellular localization, immunologic crossreactivity and physiologic function. The type II isoform encoded by this gene, is located in the mitochondria and expressed in extra-hepatic tissues, especially kidney. The physiologic role of this isoform is poorly understood\; it is thought to play a role in nitric oxide and polyamine metabolism. Transcript variants of the type II gene resulting from the use of alternative polyadenylation sites have been described. [provided by RefSeq, Jul 2008].
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories Arginase, Type II en vedette
Arginase, Type II Anticorps
High quality antibodies with extensive validation data.
Arginase, Type II Kits ELISA
Reliable ELISA kits for a wide range of species.
Arginase, Type II Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
Arginase, Type II recommandé Anticorps
Produit
Reactivity
Application
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Application
WB, ELISA, ICC, IHC (p), IHC (fro)
Validations
- (4)
N° du produit
ABIN7435613
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Human
Application
WB, ELISA, IHC, IP
Validations
- (4)
N° du produit
ABIN7144586
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Human
Application
WB, IHC (p), IHC (fro)
Validations
- (2)
- (3)
N° du produit
ABIN2855753
Quantité
100 μL
Fiche technique
Fiche technique
Arginase, Type II recommandé Kits ELISA
Produit
Reactivity
Analytical Method
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Analytical Method
Quantitative Sandwich ELISA
Validations
- (2)
- (1)
N° du produit
ABIN6973928
Quantité
96 tests
Fiche technique
Fiche technique
Reactivity
Human
Analytical Method
Quantitative Sandwich ELISA
Validations
- (1)
N° du produit
ABIN6999578
Quantité
96 tests
Fiche technique
Fiche technique
Reactivity
Human
Analytical Method
Quantitative Sandwich ELISA
Validations
- (1)
N° du produit
ABIN6953914
Quantité
96 tests
Fiche technique
Fiche technique
Arginase, Type II recommandé Protéines
Produit
Reactivity
Source
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Source
Wheat germ
Validations
- (1)
N° du produit
ABIN1326602
Quantité
10 μg
Fiche technique
Fiche technique
Reactivity
Human
Source
HEK-293 Cells
Validations
- (2)
N° du produit
ABIN2714866
Quantité
20 μg
Fiche technique
Fiche technique
Reactivity
Human
Source
Escherichia coli (E. coli)
Validations
N° du produit
ABIN1097032
Quantité
50 μg
Fiche technique
Fiche technique
Dernières publications sur nos produits Arginase, Type II
: "L-Norvaline, a new therapeutic agent against Alzheimer's disease." dans: Neural regeneration research, Vol. 14, Issue 9, pp. 1562-1572, (2019) (PubMed).: "L-Norvaline Reverses Cognitive Decline and Synaptic Loss in a Murine Model of Alzheimer's Disease." dans: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, Vol. 15, Issue 4, pp. 1036-1054, (2019) (PubMed).
: "Increased asymmetric dimethylarginine levels in severe transient tachypnea of the newborn." dans: Journal of perinatology : official journal of the California Perinatal Association, Vol. 36, Issue 6, pp. 459-62, (2018) (PubMed).
: "Arginase controls soluble vascular endothelial growth factor receptor 1 (sFlt1) to maintain pregnancy homeostasis." dans: Biochemical and biophysical research communications, Vol. 499, Issue 2, pp. 150-155, (2018) (PubMed).
: "Local arginase inhibition during early reperfusion mediates cardioprotection via increased nitric oxide production." dans: PLoS ONE, Vol. 7, Issue 7, pp. e42038, (2012) (PubMed).
: "Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus." dans: Circulation, Vol. 126, Issue 25, pp. 2943-50, (2012) (PubMed).
: "Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells." dans: The Journal of clinical investigation, Vol. 121, Issue 3, pp. 1163-73, (2011) (PubMed).
: "Arginase inhibition restores in vivo coronary microvascular function in type 2 diabetic rats." dans: American journal of physiology. Heart and circulatory physiology, Vol. 300, Issue 4, pp. H1174-81, (2011) (PubMed).
: "Subcellular localization of full-length and truncated Trk receptor isoforms in polarized neurons and epithelial cells." dans: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 19, Issue 14, pp. 5823-33, (1999) (PubMed).
: "The second intracellular loop of metabotropic glutamate receptor 1 cooperates with the other intracellular domains to control coupling to G-proteins." dans: The Journal of biological chemistry, Vol. 271, Issue 4, pp. 2199-205, (1996) (PubMed).
Synonymes et noms alternatifs relatifs à Arginase, Type II
arginase 2 (ARG2), arginase type II (Arg2), arginase 2 (Arg2), arginase 2 (arg2), arginase 2 L homeolog (arg2.L), arginase 2 S homeolog (arg2.S), AII, arg1, ARG2, arg2, arg2-b, arg2-c, arg3, AU022422, LeARG2, wu:fb67g02, zgc:65793, zgc:85630Protein level used designations for Arginase, Type II
- L-arginine amidinohydrolase
- L-arginine ureahydrolase
- arginase, type II
- arginase-2, mitochondrial
- kidney arginase
- kidney-type arginase
- non-hepatic arginase
- nonhepatic arginase
- type II arginase
- AII type II arginase
- arginase II
- arginase type II
- arginase 2
- ureohydrolase
- arginase, non-hepatic 1
- arginase, non-hepatic 3
- arginase, type 2
- mitochondrial arginase 2
- mitochondrial arginase type II
- arginase-2, mitochondrial-like
- arginase 3
- arginase, non-hepatic 2
Vous êtes ici:
